Search Results

Effective Date: April 22, 2011 Revision Date: February 8, 2012; August 14, 2013; June 11, 2014 OBJECTIVE To define policies and procedures for appointing Institutional Review Board (IRB) members and for maintaining the Office for Human Research Protections (OHRP) and Food and Drug Administration (FDA) roster. GENERAL DESCRIPTION The purpose of the Institutional Review Board (IRB) is to protect the rights and welfare of human research subjects. This responsibility includes the review of all research involving human subjects, ensuring equitable selection of research subjects, and overseeing

The Operations Division will: • Facilitate, foster, cutting-edge, and support the conduct of high-quality clinical research • Increase studies that provide patients with access to, research opportunities • Serve as a shared resource to investigators and research coordinators. Services include: • Research nurse/coordinator support for study start-up, follow-up, and closeout • Screen and identify eligible patients • Contract and budgeting • IRB preparation, submission, and continuing review • Educational opportunities

Purpose An operative performance rating system (OPRS) for Urology residents was developed for 6 sentinel urological procedures. This study tests the reliability, validity, and feasibility of an OPRS for Urology residents. Materials and Methods Each procedure OPRS contained a 3-point case difficulty scale, 4 to 6 procedure specific items, 3 general items, and an overall performance item. A Likert scale of 1 to 5 was used for each item. A single video/audio record of each procedure was evaluated by the faculty, and single-item inter-rater agreement was measured by comparison of the observed

The United States is in the midst of an opioid overdose epidemic. Opioids (including prescription opioids and heroin) killed more than 33,000 people in 2015, more than any year on record, according to the Centers for Disease Control and Prevention. Nearly half of all opioid overdose deaths involve a prescription pain reliever. More Illinoisans die from opioid drug overdoses than from motor vehicle accidents or all gun-related causes. An educational conference will address issues surrounding the opioid prescription drug and heroin epidemic, starting at 8:30 a.m. on June 6 at the Mount Vernon

3rd WEDNESDAY of each month from 12 p.m. - 1 p.m. (CDT) September 2024 - April 2025 This ECHO, coordinated by the Department of Psychiatry at SIU School of Medicine, aims to create a network of trained providers with DATA-2000 waivers who will improve access and care for patients with opioid addiction. The Opioid ECHO will also train clinicians who have the DATA-2000 waiver but who are not yet prescribing. Project ECHO® (Extension for Community Healthcare Outcomes) is a movement to demonopolize knowledge and amplify the capacity to provide best-practice care for underserved people all over the

This blog is for informational and educational purposes only. The information, in whatever form, does not constitute medical advice, is not intended to be a substitute for medical advice and should not be used as a substitute for medical care and treatment. You should always contact your physician or qualified health care provider to determine what is appropriate for your health care needs and to answer questions that you may have regarding your health, medical condition or course of treatment. SIU internist Dr. Rexanne Caga-anan regularly sees new patients asking for refills of their

Supplemental life insurance coverage is available for employees to purchase with payroll-deducted premiums. This portable term life coverage is available for employees, spouses, and children. Participation in this plan is in addition to and separate from the State of Illinois Life Insurance Program. Employees may enroll in this optional life insurance program at the time of hire, during announced open enrollment periods, or any other time with approval after providing proof of good health. Voya Life Insurance brochure and forms are available on the SIU-C HR Benefits website (scroll down to

OBSERVEMDD0001 (A prospective, longitudinal, observational study to evaluate potential predictors of relapse in subjects with major depressive disorder who have responded to antidepressant treatment) Investigators : Jeffrey I. Bennett, MD (Faculty, Adult Division) Obiora Onwuameze, MD (Faculty, Adult Division) Vinod Alluri, MD (Faculty, Adult Division) Eric Black, MD (Faculty, Adult Division) Santosh Shrestha, MD (Faculty, Adult Division) Arindam Chakrabarty, MD (Resident) This multisite, industry sponsored study investigates measurable parameters predicting relapse in recurrent Major